{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:02:19Z","timestamp":1792807339231,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"13-14","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.addr.2013.07.011","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T04:50:17Z","timestamp":1374641417000},"page":"1803-1815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1317,"title":["Nanotechnology as a therapeutic tool to combat microbial resistance"],"prefix":"10.1016","volume":"65","author":[{"given":"Robert Y.","family":"Pelgrift","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.addr.2013.07.011_bb0005","first-page":"499","article-title":"Antibacterial properties of nanoparticles","volume":"30","author":"Hajipour","year":"2012","journal-title":"Trends"},{"issue":"11","key":"10.1016\/j.addr.2013.07.011_bb0010","first-page":"1475","article-title":"Antibiotic resistance: an overview of mechanisms and a paradigm shift","volume":"96","author":"Jayaraman","year":"2009","journal-title":"Curr. Sci."},{"issue":"2","key":"10.1016\/j.addr.2013.07.011_bb0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/156652409787581637","article-title":"The molecular evolution of hospital- and community-associated methicillin-resistant Staphylococcus aureus","volume":"9","author":"Deurenberg","year":"2009","journal-title":"Curr. Mol. Med."},{"issue":"11","key":"10.1016\/j.addr.2013.07.011_bb0020","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/AAC.00346-09","article-title":"VanA-type vancomycin-resistant Staphylococcus aureus","volume":"53","author":"P\u00e9richon","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.addr.2013.07.011_bb0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4161\/viru.2.5.17035","article-title":"The growing role of nanotechnology in combating infectious disease","volume":"2","author":"Blecher","year":"2011","journal-title":"Virulence"},{"issue":"2","key":"10.1016\/j.addr.2013.07.011_bb0030","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2011.07.002","article-title":"\u201cNanoantibiotics\u201d: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era","volume":"156","author":"Huh","year":"2011","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.addr.2013.07.011_bb0340","doi-asserted-by":"crossref","first-page":"0","DOI":"10.4161\/viru.20328","article-title":"The potential of nitric oxide releasing therapies as antimicrobial agents","volume":"3","author":"Schairer","year":"2012","journal-title":"Virulence"},{"issue":"22","key":"10.1016\/j.addr.2013.07.011_bb0040","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1016\/j.biomaterials.2009.03.044","article-title":"The antimicrobial efficacy of sustained release silver\u2013carbene complex-loaded l-tyrosine polyphosphate nanoparticles: characterization, in vitro and in vivo studies","volume":"30","author":"Hindi","year":"2009","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.addr.2013.07.011_bb0045","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/polym3010340","article-title":"New strategies in the development of antimicrobial coatings: the example of increasing usage of silver and silver nanoparticles","volume":"3","author":"Knetsch","year":"2011","journal-title":"Polymers"},{"issue":"6","key":"10.1016\/j.addr.2013.07.011_bb0050","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/092986710790416290","article-title":"Development of nanoparticles for antimicrobial drug delivery","volume":"17","author":"Zhang","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.addr.2013.07.011_bb0055","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/jid.2012.399","article-title":"Antimicrobial and anti-inflammatory activity of chitosan\u2013alginate nanoparticles: a targeted therapy for cutaneous pathogens","volume":"133","author":"Friedman","year":"2013","journal-title":"J. Investig. Dermatol."},{"issue":"1","key":"10.1016\/j.addr.2013.07.011_bb0060","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.biomaterials.2010.08.076","article-title":"Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids","volume":"32","author":"Huang","year":"2011","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.addr.2013.07.011_bb0065","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/jac\/dkr408","article-title":"In vitro antimicrobial studies of silver carbene complexes: activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria","volume":"67","author":"Leid","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/j.addr.2013.07.011_bb0070","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.arcmed.2005.06.009","article-title":"Resistance to antibiotics: are we in the post-antibiotic era?","volume":"36","author":"Alanis","year":"2005","journal-title":"Arch. Med. Res."},{"issue":"6","key":"10.1016\/j.addr.2013.07.011_bb0075","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1042\/BST20120179","article-title":"Resistance is futile: the bacteriocin model for addressing the antibiotic resistance challenge","volume":"40","author":"Riley","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.addr.2013.07.011_bb0080","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1038\/nm1145","article-title":"Antibacterial resistance worldwide: causes, challenges and responses","volume":"10","author":"Levy","year":"2004","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.addr.2013.07.011_bb0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"28","key":"10.1016\/j.addr.2013.07.011_bb0090","first-page":"328","article-title":"Effects of salt stress on the antimicrobial drug resistance and protein profile of Staphylococcus aureus","volume":"5","author":"Ganjian","year":"2012","journal-title":"Jundishapur J. Microbiol."},{"issue":"4","key":"10.1016\/j.addr.2013.07.011_bb0095","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11274-009-0211-3","article-title":"Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria","volume":"26","author":"Lara","year":"2010","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"9","key":"10.1016\/j.addr.2013.07.011_bb0100","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ja.2011.58","article-title":"Recent advances in materials for extended-release antibiotic delivery system","volume":"64","author":"Gao","year":"2011","journal-title":"J. Antibiot."},{"issue":"5","key":"10.1016\/j.addr.2013.07.011_bb0105","first-page":"219","article-title":"Using pharmacodynamic and pharmacokinetic concepts to optimize treatment of infectious diseases","volume":"21","author":"Quintiliani","year":"2004","journal-title":"Infect. Med."},{"issue":"s1","key":"10.1016\/j.addr.2013.07.011_bb0110","doi-asserted-by":"crossref","first-page":"55S","DOI":"10.1046\/j.1365-2672.92.5s1.8.x","article-title":"Mechanisms of bacterial biocide and antibiotic resistance","volume":"92","author":"Poole","year":"2002","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.addr.2013.07.011_bb0115","series-title":"Basic and clinical pharmacology","first-page":"831","article-title":"Sulfonamides, trimethoprim, & quinolones","author":"Deck","year":"2012"},{"issue":"Supplement 2","key":"10.1016\/j.addr.2013.07.011_bb0120","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1086\/513854","article-title":"Penicillin-binding protein-mediated resistance in pneumococci and staphylococci","volume":"179","author":"Chambers","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"25","key":"10.1016\/j.addr.2013.07.011_bb0125","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.94.25.13944","article-title":"Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum","volume":"94","author":"Triglia","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.addr.2013.07.011_bb0130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/1389450033346920","article-title":"Fluoroquinolones: structure and target sites","volume":"4","author":"Higgins","year":"2003","journal-title":"Curr. Drug Targets"},{"issue":"6","key":"10.1016\/j.addr.2013.07.011_bb0135","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/jac\/dkp111","article-title":"Mutational analysis of quinolone resistance in the plasmid-encoded pentapeptide repeat proteins QnrA, QnrB and QnrS","volume":"63","author":"Rodr\u00edguez-Mart\u00ednez","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.addr.2013.07.011_bb0140","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-2958.1999.01202.x","article-title":"The macrolide\u2013ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA","volume":"31","author":"Hansen","year":"1999","journal-title":"Mol. Microbiol."},{"issue":"1","key":"10.1016\/j.addr.2013.07.011_bb0145","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jac\/dks354","article-title":"The emerging problem of linezolid-resistant Staphylococcus","volume":"68","author":"Gu","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.addr.2013.07.011_bb0150","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/AAC.01009-09","article-title":"Updated functional classification of beta-lactamases","volume":"54","author":"Bush","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2013.07.011_bb0160","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.2147\/IJN.S33238","article-title":"Medicine at nanoscale: a new horizon","volume":"7","author":"Khan","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2013.07.011_bb0165","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.2147\/IJN.S35288","article-title":"Nanodrugs: optimism for emerging trend of multidrug resistance","volume":"7","author":"Khan","year":"2012","journal-title":"Int. J. Nanomedicine"},{"issue":"9","key":"10.1016\/j.addr.2013.07.011_bb0170","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.addr.2013.07.011_bb0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm1347","article-title":"Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase","volume":"12","author":"Robicsek","year":"2005","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.addr.2013.07.011_bb0180","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1128\/AAC.00915-06","article-title":"Prevalence in the United States of aac (6\u2032)-Ib-cr encoding a ciprofloxacin-modifying enzyme","volume":"50","author":"Park","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.addr.2013.07.011_bb0185","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/AAC.48.7.2617-2623.2004","article-title":"Dihydropteroate synthase mutations in Pneumocystis jiroveci can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model","volume":"48","author":"Iliades","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.addr.2013.07.011_bb0190","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/525536","article-title":"Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection","volume":"46","author":"Goldstein","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.addr.2013.07.011_bb0195","series-title":"Current Research, Technology and Education Topics in Applied Microbiology and Microbial Biotechnology","first-page":"845","article-title":"Advances in industrial biofilm control with micro-nanotechnology","volume":"2","author":"Ferreira","year":"2010"},{"issue":"7","key":"10.1016\/j.addr.2013.07.011_bb0200","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1128\/AAC.01803-10","article-title":"Synergistic combination of chitosan acetate with nanoparticle silver as a topical antimicrobial: efficacy against bacterial burn infections","volume":"55","author":"Huang","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.addr.2013.07.011_bb0205","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1128\/JCM.44.4.1502-1508.2006","article-title":"Isothermal amplification and molecular typing of the obligate intracellular pathogen Mycobacterium leprae isolated from tissues of unknown origins","volume":"44","author":"Groathouse","year":"2006","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.addr.2013.07.011_bb0210","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1369-5274(98)80146-X","article-title":"The diverse habitats of obligate intracellular parasites","volume":"1","author":"Hackstadt","year":"1998","journal-title":"Curr. Opin. Microbiol."},{"issue":"7","key":"10.1016\/j.addr.2013.07.011_bb0215","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3201\/eid1407.071110","article-title":"Transmission of Bartonella henselae by Ixodes ricinus","volume":"14","author":"Cott\u00e9","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.addr.2013.07.011_bb0220","series-title":"Medical Microbiology","article-title":"Rickettsiae","author":"Walker","year":"1996"},{"key":"10.1016\/j.addr.2013.07.011_bb0225","unstructured":"R.S. Porter, J.L. Kaplan (Eds.), The Merck Manual Online for healthcare professionals, infectious diseases, bacteria and anti-bacterial drugs (content last modified 2012). Retrieved from http:\/\/www.merckmanuals.com\/professional\/infectious_diseases\/bacteria_and_antibacterial_drugs\/overview_of_bacteria.html."},{"issue":"3","key":"10.1016\/j.addr.2013.07.011_bb0230","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.niox.2012.02.002","article-title":"Examination of bacterial resistance to exogenous nitric oxide","volume":"26","author":"Privett","year":"2012","journal-title":"Nitric Oxide"},{"issue":"3","key":"10.1016\/j.addr.2013.07.011_bb0235","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4161\/viru.2.3.16161","article-title":"Susceptibility of Gram-positive and-negative bacteria to novel nitric oxide-releasing nanoparticle technology","volume":"2","author":"Friedman","year":"2011","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.addr.2013.07.011_bb0240","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.niox.2008.04.003","article-title":"Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel\/glass composites","volume":"19","author":"Friedman","year":"2008","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.addr.2013.07.011_bb0245","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.4155\/tde.12.97","article-title":"Nitric oxide releasing nanoparticles: challenges and future prospects of therapeutic delivery","volume":"3","author":"Martinez","year":"2012","journal-title":"Ther. Deliv."},{"issue":"10","key":"10.1016\/j.addr.2013.07.011_bb0250","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1038\/jid.2009.95","article-title":"Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection","volume":"129","author":"Martinez","year":"2009","journal-title":"J. Investig. Dermatol."},{"issue":"4","key":"10.1016\/j.addr.2013.07.011_bb0255","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.niox.2011.09.001","article-title":"Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione","volume":"25","author":"Friedman","year":"2011","journal-title":"Nitric Oxide"},{"issue":"11","key":"10.1016\/j.addr.2013.07.011_bb0260","doi-asserted-by":"crossref","first-page":"e7804","DOI":"10.1371\/journal.pone.0007804","article-title":"Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection","volume":"4","author":"Han","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.addr.2013.07.011_bb0265","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4161\/viru.3.1.18816","article-title":"Nitric oxide nanoparticles: pre-clinical utility as a therapeutic for intramuscular abscesses","volume":"3","author":"Schairer","year":"2012","journal-title":"Virulence"},{"issue":"2","key":"10.1016\/j.addr.2013.07.011_bb0270","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4161\/viru.1.2.10038","article-title":"The use of nitric oxide releasing nanoparticles as a treatment against Acinetobacter baumannii in wound infections","volume":"1","author":"Mihu","year":"2010","journal-title":"Virulence"},{"key":"10.1016\/j.addr.2013.07.011_bb0275","series-title":"Nitric Oxide","first-page":"187","article-title":"Nitric oxide releasing nanoparticle synthesis and characterization","author":"Han","year":"2011"},{"key":"10.1016\/j.addr.2013.07.011_bb0280","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1039\/C2NR33154C","article-title":"Targeted nanoparticles for enhanced X-ray radiation killing of multidrug-resistant bacteria","volume":"5","author":"Luo","year":"2013","journal-title":"Nanoscale"},{"issue":"13","key":"10.1016\/j.addr.2013.07.011_bb0285","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1073\/pnas.1107254109","article-title":"Nanoalumina promotes the horizontal transfer of multiresistance genes mediated by plasmids across genera","volume":"109","author":"Qiu","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.addr.2013.07.011_bb0290","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1128\/AEM.06513-11","article-title":"Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus","volume":"78","author":"Brown","year":"2012","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.addr.2013.07.011_bb0295","first-page":"1175","article-title":"Antibiofilm surface functionalization of catheters by magnesium fluoride nanoparticles","volume":"7","author":"Lellouche","year":"2012","journal-title":"Int. J. Nanomedicine"},{"issue":"14","key":"10.1016\/j.addr.2013.07.011_bb0300","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/j.biomaterials.2009.01.052","article-title":"Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles","volume":"30","author":"Hetrick","year":"2009","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.addr.2013.07.011_bb0305","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/jac\/dkn034","article-title":"Antimicrobial surface functionalization of plastic catheters by silver nanoparticles","volume":"61","author":"Roe","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2013.07.011_bb0310","first-page":"2109","article-title":"Zerovalent bismuth nanoparticles inhibit Streptococcus mutans growth and formation of biofilm","volume":"7","author":"Hernandez-Delgadillo","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2013.07.011_bb0315","doi-asserted-by":"crossref","DOI":"10.1186\/1556-276X-7-501","article-title":"Magnetite nanoparticles for functionalized textile dressing to prevent fungal biofilms development","author":"Anghel","year":"2012","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.addr.2013.07.011_bb0320","doi-asserted-by":"crossref","DOI":"10.1186\/1556-276X-7-209","article-title":"Hybrid magnetite nanoparticles\/Rosmarinus officinalis essential oil nanobiosystem with antibiofilm activity","author":"Chifiriuc","year":"2012","journal-title":"Nanoscale Res. Lett."},{"issue":"3\u20134","key":"10.1016\/j.addr.2013.07.011_bb0325","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1081\/LPR-200029887","article-title":"The delivery of benzyl penicillin to Staphylococcus aureus biofilms by use of liposomes","volume":"14","author":"Kim","year":"2004","journal-title":"J. Liposome Res."},{"issue":"4","key":"10.1016\/j.addr.2013.07.011_bb0330","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.lwt.2009.12.008","article-title":"A review of current and emergent biofilm control strategies","volume":"43","author":"Sim\u00f5es","year":"2010","journal-title":"LWT Food Sci. Technol."},{"issue":"5","key":"10.1016\/j.addr.2013.07.011_bb0335","first-page":"232","article-title":"Bioinspired implant materials befuddle bacteria","volume":"70","author":"Bryers","year":"2004","journal-title":"ASM News Am. Soc. Microbiol."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X13001658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X13001658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T07:20:33Z","timestamp":1539501633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X13001658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":66,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0169409X13001658"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2013.07.011","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanotechnology as a therapeutic tool to combat microbial resistance","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2013.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}